JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs
<p>Abstract</p> <p>Background</p> <p>Microsomal transfer protein inhibitors (MTPi) have the potential to be used as a drug to lower plasma lipids, mainly plasma triglycerides (TG). However, studies with animal models have indicated that MTPi treatment results in the acc...
Main Authors: | Shrestha Sudeep, Zern Tosca L, West Kristy L, Aggarwal Dimple, Vergara-Jimenez Marcela, Fernandez Maria |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-09-01
|
Series: | BMC Cardiovascular Disorders |
Online Access: | http://www.biomedcentral.com/1471-2261/5/30 |
Similar Items
-
JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Reduces Food Preference for Fat
by: Yasuko Mera, et al.
Published: (2014-01-01) -
Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B
by: Uwe J.F. Tietge, et al.
Published: (1999-11-01) -
JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates lipid metabolism and attenuates atherosclerosis in hyperlipidemic animal models
by: Yasuko Mera, et al.
Published: (2015-11-01) -
JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Improves Hyperglycemia and Dyslipidemia Independent of Suppression of Food Intake in Diabetic Rats
by: Shohei Sakata, et al.
Published: (2014-01-01) -
Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression.
by: M C Lin, et al.
Published: (1995-05-01)